Generate Biomedicines Inc
GENB
NASDAQ
Biotechnology
$15.64
USD
+0.61 (+4.06%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.89B
Volume 306.0K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
VRDN | Viridian Therapeutics Inc | $2.48B | - | +23220.3% | - | |
PGEN | Precigen Inc | $2.33B | - | +1875.0% | - | |
ADMA | ADMA Biologics Inc | $2.19B | 12.97 | +8.0% | - | |
STOK | Stoke Therapeutics Inc | $2.04B | - | -86.2% | - | |
AGIO | Agios Pharmaceuticals Inc | $2.00B | - | +140.6% | - | |
ZBIO | Zenas Biopharma Inc | $2.00B | - | - | - | |
TSHA | Taysha Gene Therapies Inc | $1.95B | - | +3.4% | - | |
SRPT | Sarepta Therapeutics Inc | $1.94B | - | -20.4% | - | |
DMRA | Damora Therapeutics Inc | $1.90B | - | - | - | |
GENB | Generate Biomedicines Inc | $1.89B | - | - | - | |
SNDX | Syndax Pharmaceuticals Inc | $1.74B | - | +222.7% | - |
Top Peer by Growth
Viridian Therapeutics Inc
+23220.3% YoY Revenue
Lowest P/E Ratio
ADMA Biologics Inc
12.97x P/E
Best 1-Year Return
Precigen Inc
+239.8% Return